Pharmaceutical Technology
February 03, 2021
Cover Story
45
2
New approaches to clinical trials, spurred by the COVID-19 pandemic, have dramatically shortened development timeframes. Can these gains be sustained once conditions return to normal?
February 03, 2021
Peer-Reviewed Research
45
2
This article provides an overview of the key risks that can be associated with the use of secondary reference standards (RS) and illustrates scientific challenges associated with transitioning from pharmacopeial RS to secondary RS.
February 03, 2021
Development
45
2
Plasma-based proteins and cell-based therapies have significant potential to address unmet medical needs.
February 03, 2021
Development
45
2
Rapid growth in biologics and increasing complexity of new compounds are some of the factors driving development of innovative delivery solutions.
February 03, 2021
Manufacturing
45
2
Advanced manufacturing technologies are available, but challenges need to be addressed.
February 03, 2021
Manufacturing
45
2
Sharing process insights across the stages of drug development improves tech transfer.
February 03, 2021
Quality/Regulations
45
2
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
February 02, 2021
Analytics
45
2
Common approaches to analyze elemental impurities for compliance with regulatory requirements are robust but still have some limitations.
February 02, 2021
Operations
45
2
Anticounterfeiting technology protects the supply chain from manufacturer to patient.
February 02, 2021
Outsourcing
45
2
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
February 02, 2021
45
2
More work is needed to educate businesses on the value of innovation and the availability of funding.
February 02, 2021
Regulatory Watch
45
2
FDA puts applications on hold as the agency limits alternative oversight methods.
February 02, 2021
Regulatory Watch
45
2
The EC intends to get tougher on issues such as reliability of drug supplies, particularly essential medicines.
February 02, 2021
From The Editor
45
2
COVID-19 vaccine supplies are breaking news headlines, in both ‘good’ and ‘not so good’ ways.
February 02, 2021
From The Editor
45
2
Viewpoint: Mike Hennessy, Sr., founder and chairman of MJH Life Sciences, commends the leadership of the pharmaceutical industry in combatting the COVID-19 pandemic.
February 02, 2021
Ask the Expert
45
2
Experts Steven J. Lynn, executive vice-president, Pharmaceuticals for Regulatory Compliance Associates, Inc., and Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, Inc., provide simple answers to frequently asked questions regarding regulatory inspections, although many of the concepts can be applied to internal and supplier audits as well.
February 02, 2021
From The Editor
45
2
A complicated vaccination rollout and mixed messages may derail the pandemic endgame.
February 02, 2021
Product Spotlight
45
2
Romaco Innojet’s IGL 100 granulation line is intended for production-scale processing applications and combines high-shear mixing and granulation, fluid bed drying, fluid bed granulation, fluid bed pellet coating, and fluid bed hot melt coating into one unit.
February 02, 2021
Product Spotlight
45
2
Advanced i-Series liquid chromatographs from Shimadzu provide users with the ability to analyze a large number of samples and re-process data while working remotely.
February 02, 2021
Product Spotlight
45
2
The GENiSYS R from AST (pictured) is a modular system that automates aseptic filling and the closing of vials, syringes, and cartridges.
February 02, 2021
Product Spotlight
45
2
ROSS incorporated a high shear rotor/stator into its Dual-Shaft Mixer to meet more intense shearing and homogenization requirements.